Institutional Commitment to Rectal Cancer Screening Results in Earlier-Stage Cancers on Diagnosis
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Background: The Veterans Administration hospitals underwent an institutional directive in 1998 to meet a colorectal cancer screening (CRCS) standard. This intervention should result in an increase in the hospital’s screening rate and percentage of early-stage rectal cancers diagnosed.
Methods: A retrospective review, from 1991 to 2002, of our institution’s pathology and cancer registry databases for rectal cancers. CRCS data were obtained from the Veterans Administration Prevention Disease Index. Cancer stage at diagnosis was compared before and after the directive and was compared with the National Cancer Data Base and the Surveillance, Epidemiology, and End Results data.
Results: The rate of CRCS was 55% in 1998 and increased to 75% in 2003. During the 11 years studied, a total of 147 rectal cancers were diagnosed. After the Veterans Administration directive, there was a significant increase in stage 0 cancers (P < .02) and an overall migration to earlier-stage cancers. Our Veterans Administration hospital had a significantly greater percentage of stage 0 cancers both before (P < .007) and after the directive (P < .00) and had fewer stage 3 cancers after the directive (P < .03) compared with National Cancer Data Base data. Compared with Surveillance, Epidemiology, and End Results data, the Palo Alto Veterans Affairs Health Care System had more local disease (P < .03) and less regional disease (P < .006).
Conclusions: These data suggest that a monitored institutional directive may significantly increase early detection of rectal cancers. This should result in a greater survival rate and lower local recurrence rate, because survival is predicated on stage at presentation. This may serve as a model for other health-care systems.
- Winawer, S, Fletcher, R, Rex, D (2003) Colorectal cancer screening and surveillance: clinical guidelines and rationale—update based on new evidence. Gastroenterology 124: pp. 544-560
- Simmang, CL, Senatore, P, Lowry, A (1999) Practice parameters for detection of colorectal neoplasms. The Standards Committee, The American Society of Colon and Rectal Surgeons. Dis Colon Rectum 42: pp. 1123-1129
- Smith, RA, von Eschenbach, AC, Wender, R (2001) American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001—testing for early lung cancer detection. CA Cancer J Clin 51: pp. 38-75 CrossRef
- Screening for colorectal cancer: recommendation and rationale. Ann Intern Med 137: pp. 129-131
- Mandel, JS, Church, TR, Bond, JH (2000) The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 343: pp. 1603-1607 CrossRef
- Kronborg, O, Fenger, C, Olsen, J, Jorgensen, OD, Sondergaard, O (1996) Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 348: pp. 1467-1471
- Hardcastle, JD, Chamberlain, JO, Robinson, MH (1996) Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 348: pp. 1472-1477
- Thiis-Evensen, E, Hoff, GS, Sauar, J, Langmark, F, Majak, BM, Vatn, MH (1999) Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scand J Gastroenterol 34: pp. 414-420
- Selby, JV, Friedman, GD, Quesenberry, CP, Weiss, NS (1992) A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 326: pp. 653-657 CrossRef
- Winawer, SJ, Flehinger, BJ, Schottenfeld, D, Miller, DG (1993) Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. J Natl Cancer Inst 85: pp. 1311-1318
- Lieberman, DA, Weiss, DG, Bond, JH, Ahnen, DJ, Garewal, H, Chejfec, G (2000) Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med 343: pp. 162-168 CrossRef
- Nelson, DB, McQuaid, KR, Bond, JH, Lieberman, DA, Weiss, DG, Johnston, TK (2002) Procedural success and complications of large-scale screening colonoscopy. Gastrointest Endosc 55: pp. 307-314
- Winawer, SJ, Stewart, ET, Zauber, AG (2000) A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy. National Polyp Study Work Group. N Engl J Med 342: pp. 1766-1772 CrossRef
- Muller, AD, Sonnenberg, A (1995) Protection by endoscopy against death from colorectal cancer. A case-control study among veterans. Arch Intern Med 155: pp. 1741-1748 CrossRef
- Vijan, S, Hwang, EW, Hofer, TP, Hayward, RA (2001) Which colon cancer screening test? A comparison of costs, effectiveness, and compliance. Am J Med 111: pp. 593-601
- Pignone, M, Saha, S, Hoerger, T, Mandelblatt, J (2002) Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 137: pp. 96-104
- Sonnenberg, A, Delco, F, Inadomi, JM (2000) Cost-effectiveness of colonoscopy in screening for colorectal cancer. Ann Intern Med 133: pp. 573-584
- Loeve, F, Brown, ML, Boer, R, van Ballegooijen, M, van Oortmarssen, GJ, Habbema, JD (2000) Endoscopic colorectal cancer screening: a cost-saving analysis. J Natl Cancer Inst 92: pp. 557-563
- Ness, RM, Holmes, AM, Klein, R, Dittus, R (2000) Cost-utility of one-time colonoscopic screening for colorectal cancer at various ages. Am J Gastroenterol 95: pp. 1800-1811
- Colorectal cancer test use among persons aged > or = 50 years—United States, 2001. MMWR Morb Mortal Wkly Rep 2003; 52: 193–6.
- California Cancer Facts and Figures 2004. American Cancer Society, California Division, Oakland, CA
- Breen, N, Wagener, DK, Brown, ML, Davis, WW, Ballard-Barbash, R (2001) Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys. J Natl Cancer Inst 93: pp. 1704-1713
- VHA Performance Measurement Data: EPRP Reports. Washington, DC: Office of Quality and Performance, Veterans Health Administration, Department of Veterans Affairs, 1999–2003.
- VHA Performance Measurement Technical Manual. Washington, DC: Office of Quality and Performance (10Q), Veterans Health Administration, Department of Veterans Affairs, 2002.
- Ries LAG, Eisner MP, Kosary CL, et al. (eds). SEER cancer statistics review, 1975–2000. Bethesda, MD: National Cancer Institute, 2003. Available at: http://seer.cancer.gov/csr/1975_2000. Accessed: March 6, 2004.
- National Cancer Data Base, Commission on Cancer. Benchmark reports, version 2.0. American College of Surgeons. http://web.facs.org/ncdbbmr/ncdbbenchmarks.cfm. Accessed: March 6, 2004.
- Winawer, SJ (2001) A quarter century of colorectal cancer screening: progress and prospects. J Clin Oncol 19: pp. 6S-12S
- Winawer, SJ, Zauber, AG, O’Brien, MJ (1992) The National Polyp Study. Design, methods, and characteristics of patients with newly diagnosed polyps. The National Polyp Study Workgroup. Cancer 70: pp. 1236-1245
- Brenes, GA, Paskett, ED (2000) Predictors of stage of adoption for colorectal cancer screening. Prev Med 31: pp. 410-416
- Rabeneck, L, Souchek, J, El-Serag, HB (2003) Survival of colorectal cancer patients hospitalized in the Veterans Affairs Health Care System. Am J Gastroenterol 98: pp. 1186-1192
- Ramsey, SD, Mandelson, MT, Berry, K, Etzioni, R, Harrison, R (2003) Cancer-attributable costs of diagnosis and care for persons with screen-detected versus symptom-detected colorectal cancer. Gastroenterology 125: pp. 1645-1650
- Cheng, X, Chen, VW, Steele, B (2001) Subsite-specific incidence rate and stage of disease in colorectal cancer by race, gender, and age group in the United States, 1992–1997. Cancer 92: pp. 2547-2554 CrossRef
- Fleming, ID, Cooper, JS, Hensen, DE (1997) American Joint Commission on Cancer (AJCC) Staging Manual. Lippincott-Raven, Philadelphia
- Institutional Commitment to Rectal Cancer Screening Results in Earlier-Stage Cancers on Diagnosis
Annals of Surgical Oncology
Volume 11, Issue 11 , pp 970-976
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Colorectal cancer
- Rectal cancer
- Cancer staging
- Industry Sectors
- Author Affiliations
- 3. Stanford University School of Medicine, Stanford University, Palo Alto, California
- 1. Departments of Pathology, Stanford University, Palo Alto, California
- 4. Palo Alto Veterans Affairs Health Care System, Palo Alto, California
- 2. Departments of Surgery, Stanford University, Palo Alto, California
- 5. Stanford University Department of Surgery, G112 PAVAHCS, 3801 Miranda Avenue, Palo Alto, CA, 94304